1. Home
  2. PSEC vs AMPH Comparison

PSEC vs AMPH Comparison

Compare PSEC & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prospect Capital Corporation

PSEC

Prospect Capital Corporation

HOLD

Current Price

$2.63

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$29.33

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSEC
AMPH
Founded
2004
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2004
2014

Fundamental Metrics

Financial Performance
Metric
PSEC
AMPH
Price
$2.63
$29.33
Analyst Decision
Sell
Buy
Analyst Count
1
6
Target Price
$2.50
$31.00
AVG Volume (30 Days)
3.9M
332.7K
Earning Date
02-09-2026
02-26-2026
Dividend Yield
20.45%
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.27
Revenue
$680,752,000.00
$723,305,000.00
Revenue This Year
N/A
$1.37
Revenue Next Year
N/A
$4.84
P/E Ratio
N/A
$12.89
Revenue Growth
N/A
N/A
52 Week Low
$2.45
$20.39
52 Week High
$4.47
$33.42

Technical Indicators

Market Signals
Indicator
PSEC
AMPH
Relative Strength Index (RSI) 40.56 66.12
Support Level $2.68 $28.45
Resistance Level $2.77 $29.37
Average True Range (ATR) 0.08 0.86
MACD -0.03 0.28
Stochastic Oscillator 2.84 93.33

Price Performance

Historical Comparison
PSEC
AMPH

About PSEC Prospect Capital Corporation

Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests mainly in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: